Discover
TOI
The Oncology Institute, Inc.
5.51
2 x 4.03
2 x 6.86
bid
ask
+
0.08
1.47%
2 @ 04:00 PM
5.60 +0.09 (1.63%)
| Ytd | 54.78% | |
| 1y | 150.45% |
5.36
day range
5.62
2.19
52 week range
5.82
| Open | 5.36 | Prev Close | 5.43 | Low | 5.36 | High | 5.62 | Mkt Cap | 550.91M |
| Vol | 1.54M | Avg Vol | 1.71M | EPS | -0.35 | P/E | N/A | Forward P/E | -1.28 |
| Beta | 0.62 | Short Ratio | 3.38 | Inst. Own | 47.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 4.46 | 200-d Avg | 3.65 | 1yr Est | 2.00 |
| Income Statement | |||
| Total Revenue | 147.44M | ||
| Revenues (USD) | 147.44M | ||
| Cost of Revenue | 124.13M | ||
| Gross Profit | 23.32M | ||
| Operating Expenses | 29.83M | ||
| Selling, General and Administrative Expense | 28.21M | ||
| Operating Income | -6.51M | ||
| Interest Expense | 1.93M | ||
| Net Income | -2.09M | ||
| Net Income Common Stock | -2.09M | ||
| Net Income Common Stock (USD) | -2.09M | ||
| Consolidated Income | -2.49M | ||
| Net Income to Non-Controlling Interests | -398.00K | ||
| Earnings per Basic Share | -0.02 | ||
| Earnings per Basic Share (USD) | -0.02 | ||
| Earnings per Diluted Share | -0.02 | ||
| Earning Before Interest & Taxes (EBIT) | -160.00K | ||
| Earning Before Interest & Taxes (USD) | -160.00K | ||
| Weighted Average Shares | 101.80M | ||
| Weighted Average Shares Diluted | 101.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 30.28M | ||
| Cash and Equivalents (USD) | 30.28M | ||
| Trade and Non-Trade Receivables | 59.45M | ||
| Current Assets | 116.86M | ||
| Property, Plant & Equipment Net | 33.22M | ||
| Total Assets | 168.23M | ||
| Debt Current | 7.40M | ||
| Total Debt | 104.86M | ||
| Current Liabilities | 79.35M | ||
| Debt Non-Current | 97.45M | ||
| Total Liabilities | 184.52M | ||
| Accumulated Retained Earnings (Deficit) | -273.91M | ||
| Shareholders Equity | -16.28M | ||
| Shareholders Equity (USD) | -16.28M | ||
| Assets Non-Current | 51.37M | ||
| Total Debt (USD) | 104.86M | ||
| Goodwill and Intangible Assets | 17.53M | ||
| Inventory | 24.29M | ||
| Liabilities Non-Current | 105.16M | ||
| Trade and Non-Trade Payables | 47.65M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.62M | ||
| Net Cash Flow from Financing | -28.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.28M | ||
| Capital Expenditure | -1.04M | ||
| Issuance (Purchase) of Equity Shares | 241.00K | ||
| Issuance (Repayment) of Debt Securities | -269.00K | ||
| Net Cash Flow from Investing | -1.04M | ||
| Net Cash Flow from Operations | -2.21M | ||
| Share Based Compensation | 1.69M | ||